© 2021 MJH Life Sciences and Pharmacy Times. All rights reserved.
© 2021 MJH Life Sciences™ and Pharmacy Times. All rights reserved.
April 14, 2021
Lakesha M. Butler, PharmD, BCPS, diversity and inclusion coordinator and clinical professor at Southern Illinois University Edwardsville, discussed causes of health inequity and how pharmacists can prevent and mitigate them to improve patient outcomes.
Before the COVID-19 pandemic, pharmacy technicians spent most of their shifts helping patients, billing insurance, stocking the pharmacy area, dispensing prescriptions, and other administrative duties. However, COVID-19 quickly changed that.
Errors related to extended-release opioids and COVID-19 vaccines warrant attention and should be a priority.
April 13, 2021
Nearly half of independent pharmacists surveyed by the National Community Pharmacists Association are not getting enough or any doses of the COVID-19 vaccine.
As the FDA and CDC have paused use of the Johnson & Johnson COVID-19 vaccine in the United States, research is ongoing to understand whether cerebral venous sinus thrombosis (CVST) is directly linked to the vaccine.
The FDA and CDC said that 6 women experienced cerebral venous thrombosis, an extremely rare disorder associated with blood clotting, 6 to 16 days after the Johnson & Johnson COVID-19 vaccine was administered.
April 12, 2021
The pharmacist is the last barrier between a patient and a drug, which is why it's critical for pharmacists to check for allergies, potential drug interactions, patient understanding of how to use the drug, and whether the prescription is appropriate for the diagnosis.
April 09, 2021
COVID-19 has increased the demand for new, safer curbside conveniences and the health care industry—including the pharmacy—has transformed rapidly to meet patient needs and prioritize safety as a result of the pandemic.
The most common reason given for refusal of a COVID-19 vaccine was distrust of the health care system, correctional or government personnel, and institutions.
April 08, 2021
Indicators of the COVID-19 pandemic’s impact, including testing rates, positivity ratio, case rates by overall population, and deaths, are clustered by neighborhood, with low-income and predominantly minority communities experiencing worse outcomes.